Melocox

Meloxicam, the active ingredient in Melocox, is a Nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for oral use. It treats pain and inflammation associated with osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute pain in adult patients.

GNH USA supplies Melocox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Meloxicam is an NSAID that reduces inflammation and pain in several musculoskeletal conditions.

- Osteoarthritis: alleviates joint pain and improves functional mobility. - Rheumatoid arthritis: decreases synovial inflammation and limits disease‑related damage. - Ankylosing spondylitis: relieves spinal stiffness and pain. - Acute pain: provides short‑term relief of moderate pain episodes.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Gastrointestinal upset: nausea, dyspepsia, or abdominal discomfort. - Headache: mild to moderate intensity. - Dizziness or vertigo. - Peripheral edema: swelling of the lower limbs. - Elevated blood pressure. - Skin rash or pruritus.

Serious or Rare Side Effects: - Gastrointestinal ulceration or bleeding. - Cardiovascular events such as myocardial infarction or stroke. - Hepatic enzyme elevation indicating liver stress. - Severe skin reactions, including Stevens‑Johnson syndrome. - Acute renal impairment or failure. - Anaphylactic or severe allergic reactions.

Before initiating meloxicam, clinicians should evaluate patient‑specific risk factors and monitor for potential complications.

- Assess gastrointestinal risk: avoid in patients with active peptic ulcer disease. - Monitor renal function: adjust or discontinue if creatinine rises. - Review cardiovascular status: use cautiously in patients with heart disease. - Check for concurrent NSAID use: avoid combined therapy to reduce toxicity. - Evaluate hepatic health: monitor liver enzymes periodically. - Store at ambient temperature: keep below 25°C in the original packaging, protect from moisture.

Meloxicam can interact with several drug classes, requiring careful management.

Major Interactions (Avoid): - Warfarin: increased risk of serious bleeding. - Lithium: heightened lithium serum concentrations. - Methotrexate: amplified methotrexate toxicity.

Moderate Interactions (Monitor Closely): - SSRIs: additive bleeding risk. - ACE inhibitors: possible reduction in renal function. - Diuretics: may affect renal clearance of meloxicam.